[go: up one dir, main page]

WO2019008210A3 - Composicion que comprende micropartícula para la resección endoscópica - Google Patents

Composicion que comprende micropartícula para la resección endoscópica Download PDF

Info

Publication number
WO2019008210A3
WO2019008210A3 PCT/ES2018/070478 ES2018070478W WO2019008210A3 WO 2019008210 A3 WO2019008210 A3 WO 2019008210A3 ES 2018070478 W ES2018070478 W ES 2018070478W WO 2019008210 A3 WO2019008210 A3 WO 2019008210A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
microparticles
resection
endoscopic resection
hyaluronic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2018/070478
Other languages
English (en)
French (fr)
Other versions
WO2019008210A2 (es
Inventor
José Antonio MORALES MOLINA
Beatriz CLARES NAVEROS
Francisco Javier GALLEGO ROJO
María José MARTÍN VILLENA
Cristina MOLES ARANDA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Granada
Servicio Andaluz de Salud
Original Assignee
Universidad de Granada
Servicio Andaluz de Salud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Granada, Servicio Andaluz de Salud filed Critical Universidad de Granada
Publication of WO2019008210A2 publication Critical patent/WO2019008210A2/es
Publication of WO2019008210A3 publication Critical patent/WO2019008210A3/es
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una preparación combinada que comprende al menos una micropartícula y una composición, preferiblemente una solución farmacéutica acuosa, que comprende un polímero derivado de celulosa soluble en agua y ácido hialurónico, preferiblemente que comprende carboximetilcelulosa y ácido hialurónico. Asimismo, hace referencia al uso de dicha preparación combinada en la elaboración de un medicamento para el tratamiento de lesiones mucosas mediante resección endoscópica, por ejemplo, la resección de pólipos y/o tumores de la mucosa gastrointestinal.
PCT/ES2018/070478 2017-07-04 2018-07-04 Micropartículas que comprenden una composición para la resección endoscópica Ceased WO2019008210A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201730889 2017-07-04
ESP201730889 2017-07-04

Publications (2)

Publication Number Publication Date
WO2019008210A2 WO2019008210A2 (es) 2019-01-10
WO2019008210A3 true WO2019008210A3 (es) 2019-03-07

Family

ID=64949756

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ES2018/070478 Ceased WO2019008210A2 (es) 2017-07-04 2018-07-04 Micropartículas que comprenden una composición para la resección endoscópica

Country Status (1)

Country Link
WO (1) WO2019008210A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115844816A (zh) * 2022-05-30 2023-03-28 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种粘膜下注射液

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150099928A1 (en) * 2013-10-07 2015-04-09 Boston Scientific Scimed, Inc. Injectable compositions
WO2016074794A1 (en) * 2014-11-13 2016-05-19 Merz Pharma Gmbh & Co. Kgaa Dermal filler based on crosslinked hyaluronic acid and carboxymethyl cellulose lubricant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150099928A1 (en) * 2013-10-07 2015-04-09 Boston Scientific Scimed, Inc. Injectable compositions
WO2016074794A1 (en) * 2014-11-13 2016-05-19 Merz Pharma Gmbh & Co. Kgaa Dermal filler based on crosslinked hyaluronic acid and carboxymethyl cellulose lubricant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HIKICHI T. ET AL.: "Sal766 Novel Injection Technique: Endoscopic Submucosal Dissection by Submucosal Injection of Sodium Carboxymethylcellulose for Early Gastric Cancer", GASTROINTESTINAL ENDOSCOPY, vol. 75, no. 4S, 2012, pages AB269, XP028920348 *
URAOKA T. ET AL.: "Submucosal injection solution for gastrointestinal tract endoscopic mucosal resection and endoscopic submucosal dissection", DRUG DESIGN, DEVELOPMENT AND THERAPY, vol. 2, 2008, pages 131 - 138, XP009504388 *

Also Published As

Publication number Publication date
WO2019008210A2 (es) 2019-01-10

Similar Documents

Publication Publication Date Title
MA64509B1 (fr) Composés hétérocycliques utilisés comme immunomodulateurs
MA64121B1 (fr) Composés hétérocycliques utilisés comme immunomodulateurs
EA200100872A1 (ru) Композиция валдекоксиба
MA43605A1 (fr) Isoquinolin-3-yl carboxamides et préparation et utilisation de ceux-ci
MA39783A (fr) Dérivés de quinoxaline utiles en tant que modulateurs de la fgfr kinase
WO2007075598A3 (en) N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
MA35411B1 (fr) Nouvelle composition thérapeutique contenant de l'apomorphine comme principe actif
CA2435419A1 (fr) Composition halogenee, son procede de preparation et ses utilisations
CA3155883A1 (en) BUCCO-DENTAL CARE COMPOSITIONS BASED ON BETA ACID OF HOPS AND AMINO ACID
MA43876B1 (fr) Compositions pharmaceutiques et leur utilisations contre les maladies de surcharge lysosomale
CN111770756A (zh) 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途
FR2952372B1 (fr) Nouveaux derives de mannopyranoside ayant une activite anticancereuse
FR3033701B1 (fr) Nouvelles compositions antivirales pour le traitement de la grippe
WO2019008210A3 (es) Composicion que comprende micropartícula para la resección endoscópica
WO2024099364A3 (en) Fused multicyclic compounds and their use as parp1 inhibitors
EA202190510A1 (ru) Новое лекарственное средство для лечения воспалительной болезни кишечника
MA40937A (fr) Acide benzoïque, dérivés d'acide benzoïque et conjugués d'acide hétéroarylcarboxylique d'oxymorphone, promédicaments, leurs procédés de fabrication et d'utilisation
MA48919A (fr) Compositions ophtalmiques contenant un prostamide libérant de l'oxyde nitrique
MX2024003015A (es) Nuevos derivados de quinolina.
SA521430791B1 (ar) مترافقات هيالورونان واستعمالاتها
TN2015000176A1 (fr) Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
MX2025010547A (es) Co-cristales y sales de 8-cloro-n-(4-(trifluorometoxi)fenil)quinolin-2-amina
WO2016180363A1 (en) Chitosan citrate and composition containing same
BR112022019403A2 (pt) Uso de um derivado de tienopiridona no tratamento de doença renal policística autossômica dominante (drpad)
EP4205737A4 (en) Composition for prevention, amelioration, or treatment of inflammatory diseases or immune diseases comprising gancaonin n as active ingredient

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18828222

Country of ref document: EP

Kind code of ref document: A2